Rivaroxaban CAS 366789-02-8 Bohloeki >99.5% (HPLC) Factory API High Quality
Manufacturer Supply Rivaroxaban Related Intermediates:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4-(4-Aminophenyl)morpholin-3-one CAS 438056-69-0
Rivaroxaban Intermediate CAS 446292-07-5
5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
Rivaroxaban API CAS 366789-02-8
Lebitso la Lik'hemik'hale | Rivaroxaban |
Litlhaloso tse tšoanang | (S)-Rivaroxaban;(S) -5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;BAY 59-7939 |
Nomoro ea CAS | 366789-02-8 |
Boemo ba Setoko | Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane |
Foromo ea limolek'hule | C19H18ClN3O5S |
Boima ba Molek'hule | 435.88 |
Brand | Ruifu Chemical |
Ntho | Litlhaloso |
Ponahalo | Phofo e Tshweu kapa e Batlileng e Tshweu |
Boitsebiso A | Ho kenngoa ha infrared ha Rivaroxaban ho lumellana le litekanyetso tsa litšupiso |
Boitsebiso B | Nako ea ho boloka tlhōrō ea tlhōrō e kholo ea tharollo ea sampole e lumellana le ea tharollo ea ts'ebetso ea ts'ebetso, joalo ka ha e fumanoa ka ho hloeka ha enantiomeric. |
Enantiomeric Bohloeki | RVX RC01: ≤0.15% |
Mongobo (KF) | ≤0.50% |
Molora oa Sulfate | ≤0.10% |
Litšepe tse boima | ≤20ppm |
Acetic Acid | ≤5000ppm |
Lintho tse Amanang (HPLC) | |
RVX RC02 | ≤0.15% |
RVX RC03 | ≤0.15% |
RVX RC04 | ≤0.15% |
RVX RC05 | ≤0.15% |
RVX RC06 | ≤0.15% |
RVX RC07 | ≤0.15% |
RVX RC08 | ≤0.15% |
Tšilafalo Efe E 'ngoe ea Motho ka Mong | ≤0.10% |
Litšila ka Kakaretso | <0.50% |
Residual Solvents (GC) | |
Ethanol | ≤5000ppm |
Toluene | ≤890ppm |
Triethylamine | ≤320ppm |
Mokhoa oa Bohloeki / Analysis | >99.5% (HPLC) (ka lebaka la anhydrous basis) |
Tekanyetso ea Teko | Maemo a Khoebo |
Tšebeliso | API;Lithethefatsi tsa antithrombotic;FXa Inhibitor |
Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo.
Rivaroxaban(CAS:366789-02-8) (Xarelto, Bayer) ke anticoagulant ea molomo.Ke ntho e sebetsang ka molomo e tobileng Xa inhibitor.Rivaroxaban e bontšoa bakeng sa 'phekolo ea thrombosis ea methapo e tebileng le embolism ea pulmonary, le thibelo ea ho ipheta-pheta ha methapo e tebileng ea methapo le embolism ea pulmonary ho batho ba baholo'.Bakeng sa kalafo ea pele ea acute pulmonary embolism, tekanyetso e khothaletsoang ea rivaroxaban ke 15 mg habeli ka letsatsi bakeng sa matsatsi a pele a 21 e lateloa ke 20 mg hang ka letsatsi bakeng sa kalafo e tsoelang pele le ho thibela thromboembolism ea venous khafetsa.Non-Valvular Atrial Fibrillation (NVAF) ho thibela lefu la stroke & systemic embolism.Kalafo e matla ea VTE le thibelo ea VTE e iphetang [bakeng sa thrombosis e tebileng ea methapo (DVT) le pulmonary embolism (PE)].Thibelo ea liketsahalo tsa venous thromboembolic (VTE) ho opereishene e ikhethileng ea letheka kapa lengole (THR, TKR).